Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)
| Image |  |
|---|---|
| Description | scientific article published on 24 August 2020 |
| Author/s |
author: Toshinari Yamashita Norikazu Masuda Masakazu Toi Shinji Ohno |
| Publication date | August 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |